BOC Sciences is committed to providing one-stop Proteolysis Targeting Chimeric (PROTAC®), which has become a promising strategy in the field of drug discovery.
An Overview of Membrane-Associated E3 Ubiquitin Ligases Application of PROTAC in the Treatment of NSCLC BioPROTAC: A Complementary Approach of PROTAC for Protein Degradation Design Principles of PROTAC Delivery Systems Development of Deubiquitinase-targeting Chimeras (DUBTACs) Emergence of Research in Pro-PROTACsAt BOC Sciences, you will work with people who are enthusiastic and passionate about science and technology. Join our team and build your career with us!
For More PositionsAs a leading service provider in drug discovery and research, BOC Sciences is fully capable and committed to providing one-stop Proteolysis Targeting Chimeric (PROTAC®) services to customers around the world to meet new drug discovery goals.